间歇性喘和儿童严重恶化的风险
Shahid Sheikh1, Mariah Eisner2, Wheaton Kelin3
1Department of Pediatrics, Ohio State University College of Medicine, Columbus, Ohio, USA; Division of Pulmonary Medicine, Columbus, Ohio, USA; Nationwide Children's Hospital, Columbus, Ohio, USA.
Chest
|August 29, 2025
概括
一组轻度喘患者的严重恶化风险非常低. 目前的GINA指导方针对于这种低风险群体可能不必要或不具有成本效益.
科学领域:
- 儿童肺病学
- 喘治疗方法
- 公共卫生
背景情况:
- 由于严重恶化的风险,目前的GINA指导方针建议不要单独使用短效β-激动剂 (SABA) 治疗轻度喘.
- 目前尚不清楚所有轻度喘患者是否具有相同的严重恶化风险.
研究的目的:
- 确定某一小组轻度喘患者是否具有严重喘恶化风险非常低.
- 评估当前治疗指南的成本效益.
主要方法:
- 从俄俄州医疗补助申请数据中确定了一组2至18岁的间歇性喘患者.
- 根据在前两年给予SABA的情况,确定了一个低风险组.
- 在第三年,将低风险组与其余队列之间的严重喘恶化风险进行了比较.
主要成果:
- 有13,208名患者符合纳入标准. 低风险组 (3, 935名患者) 的住院率 (0. 08%) 和ED/ UC访问率 (0. 97%/ 0.55%) 显著降低,每年使用0-2个SABA.
- 与高风险患者相比,低风险组的相对住院风险为0. 17 (95% CI: 0. 06, 0.52) 和严重恶化为0. 18 (95% CI: 0. 13, 0. 27).
- 在低风险队列中预防一次住院需要治疗5535名患者,每次住院费用为779,716美元.
结论:
- 一个小组的轻度喘患者有明显较低的住院和严重恶化的风险.
- 目前的GINA第一步治疗建议可能对这种已确定低风险人群不必要且不具有成本效益.
- 基于风险分层的个性化喘管理策略需要进一步研究.
相关概念视频
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:24Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
01:20Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
383
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
383